The latest research study “Allergy Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global allergy treatment market size reached US$ 19.69 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 28.78 Billion by 2027, exhibiting a growth rate (CAGR) of 6.20% during 2022-2027.
Allergy treatment represents a preventive medical cure for abnormal reactions to allergens, such as molds, animal dander, pollens, latex, insects, food, medications, etc. They usually trigger the release of histamine by the immune system that causes rashes, itchiness, inflammation, sneezing, runny nose, red eyes, etc., and also various allergic conditions, including hay fever, asthma, rhinitis, and skin, eye allergies, etc. Allergy treatment usually includes immunotherapy and anti-allergic drugs that can be administered via inhalers and intranasal dosage forms. In line with this, these treatment methods aid in reducing sensitivity and inflammation, decreasing symptoms, improving the lives of patients, etc.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/allergy-treatment-market/requestsample
Allergy Treatment Market Trends and Drivers:
The growing prevalence of several allergies is primarily driving the allergy treatment market. Additionally, the launch of numerous favorable policies by government bodies and non-governmental organizations (NGOs) to sensitize individuals regarding the adversities of allergic conditions and their appropriate treatment options, and the expanding geriatric population are further catalyzing the market growth. Besides this, the escalating demand for over-the-counter (OTC) drugs, the increasing consumer inclination towards self-medication, and continuous investments in novel treatments are acting as significant growth-inducing factors. Moreover, the rising integration of natural language processing (NLP), artificial intelligence (AI), and machine learning (ML) for predicting patient outcomes for targeted interventions, diagnosing allergic diseases, analyzing immunological data, enhancing care delivery, etc., is also positively influencing the global market. Apart from this, the elevating incidences of asthma are bolstering the market growth. Furthermore, the inflating need for subcutaneous allergen-specific immunotherapy (SCIT), owing to its safety, effectiveness, ability to alter the immune system and provide systemic relief, etc., is expected to fuel the allergy treatment market over the forecasted period.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/allergy-treatment-market
Allergy Treatment Market Report Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
AbbVie Inc., ALK-Abelló A/S, Allergopharma (Dermapharm AG), Allergy Therapeutics, Almirall S.A, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, HAL Allergy Group (Droege International Group), Leti Pharma, Nicox S.A., Sanofi S.A. and Stallergenes Greer.
The report has been segmented the market into following categories:
Breakup by Type:
- Eye Allergy
- Skin Allergy
- Food Allergy
Breakup by Treatment:
- Anti-Allergy Drugs
Breakup by Dosage Form:
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Retailers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800